165 related articles for article (PubMed ID: 37801755)
1. Immunomodulatory roles of PARPs: Shaping the tumor microenvironment, one ADP-ribose at a time.
Brooks DM; Anand S; Cohen MS
Curr Opin Chem Biol; 2023 Dec; 77():102402. PubMed ID: 37801755
[TBL] [Abstract][Full Text] [Related]
2. Chemical genetic methodologies for identifying protein substrates of PARPs.
Rodriguez KM; Cohen MS
Trends Biochem Sci; 2022 May; 47(5):390-402. PubMed ID: 34366182
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity.
Heer CD; Sanderson DJ; Voth LS; Alhammad YMO; Schmidt MS; Trammell SAJ; Perlman S; Cohen MS; Fehr AR; Brenner C
J Biol Chem; 2020 Dec; 295(52):17986-17996. PubMed ID: 33051211
[TBL] [Abstract][Full Text] [Related]
4. The Role of PARPs in Inflammation-and Metabolic-Related Diseases: Molecular Mechanisms and Beyond.
Ke Y; Wang C; Zhang J; Zhong X; Wang R; Zeng X; Ba X
Cells; 2019 Sep; 8(9):. PubMed ID: 31500199
[TBL] [Abstract][Full Text] [Related]
5. New directions in poly(ADP-ribose) polymerase biology.
Bock FJ; Chang P
FEBS J; 2016 Nov; 283(22):4017-4031. PubMed ID: 27087568
[TBL] [Abstract][Full Text] [Related]
6. Are PARPs promiscuous?
Feijs KLH; Žaja R
Biosci Rep; 2022 May; 42(5):. PubMed ID: 35380161
[TBL] [Abstract][Full Text] [Related]
7. A Potent and Selective PARP11 Inhibitor Suggests Coupling between Cellular Localization and Catalytic Activity.
Kirby IT; Kojic A; Arnold MR; Thorsell AG; Karlberg T; Vermehren-Schmaedick A; Sreenivasan R; Schultz C; Schüler H; Cohen MS
Cell Chem Biol; 2018 Dec; 25(12):1547-1553.e12. PubMed ID: 30344052
[TBL] [Abstract][Full Text] [Related]
8. New PARP targets for cancer therapy.
Vyas S; Chang P
Nat Rev Cancer; 2014 Jul; 14(7):502-9. PubMed ID: 24898058
[TBL] [Abstract][Full Text] [Related]
9. PARPs in genome stability and signal transduction: implications for cancer therapy.
Palazzo L; Ahel I
Biochem Soc Trans; 2018 Dec; 46(6):1681-1695. PubMed ID: 30420415
[TBL] [Abstract][Full Text] [Related]
10. A quantitative assay reveals ligand specificity of the DNA scaffold repair protein XRCC1 and efficient disassembly of complexes of XRCC1 and the poly(ADP-ribose) polymerase 1 by poly(ADP-ribose) glycohydrolase.
Kim IK; Stegeman RA; Brosey CA; Ellenberger T
J Biol Chem; 2015 Feb; 290(6):3775-83. PubMed ID: 25477519
[TBL] [Abstract][Full Text] [Related]
11. Uncovering the Invisible: Mono-ADP-ribosylation Moved into the Spotlight.
Hopp AK; Hottiger MO
Cells; 2021 Mar; 10(3):. PubMed ID: 33808662
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms governing PARP expression, localization, and activity in cells.
Sanderson DJ; Cohen MS
Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):541-554. PubMed ID: 32962438
[TBL] [Abstract][Full Text] [Related]
13. Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.
Lu AZ; Abo R; Ren Y; Gui B; Mo JR; Blackwell D; Wigle T; Keilhack H; Niepel M
Biochem Pharmacol; 2019 Sep; 167():97-106. PubMed ID: 31075269
[TBL] [Abstract][Full Text] [Related]
14. [Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1].
Kurgina TA; Lavrik OI
Mol Biol (Mosk); 2023; 57(2):254-268. PubMed ID: 37000654
[TBL] [Abstract][Full Text] [Related]
15. Poly (ADP-Ribose) Polymerases (PARPs) and PARP Inhibitor-Targeted Therapeutics.
Li N; Wang Y; Deng W; Lin SH
Anticancer Agents Med Chem; 2019; 19(2):206-212. PubMed ID: 30417796
[TBL] [Abstract][Full Text] [Related]
16. Identification of Poly(ADP-Ribose) Polymerase Macrodomain Inhibitors Using an AlphaScreen Protocol.
Ekblad T; Verheugd P; Lindgren AE; Nyman T; Elofsson M; Schüler H
SLAS Discov; 2018 Apr; 23(4):353-362. PubMed ID: 29316839
[TBL] [Abstract][Full Text] [Related]
17. TCDD-inducible poly-ADP-ribose polymerase (TIPARP/PARP7) mono-ADP-ribosylates and co-activates liver X receptors.
Bindesbøll C; Tan S; Bott D; Cho T; Tamblyn L; MacPherson L; Grønning-Wang L; Nebb HI; Matthews J
Biochem J; 2016 Apr; 473(7):899-910. PubMed ID: 26814197
[TBL] [Abstract][Full Text] [Related]
18. PARPs and ADP-ribosylation: Deciphering the complexity with molecular tools.
Dasovich M; Leung AKL
Mol Cell; 2023 May; 83(10):1552-1572. PubMed ID: 37119811
[TBL] [Abstract][Full Text] [Related]
19. A Simple, Sensitive, and Generalizable Plate Assay for Screening PARP Inhibitors.
Kirby IT; Morgan RK; Cohen MS
Methods Mol Biol; 2018; 1813():245-252. PubMed ID: 30097873
[TBL] [Abstract][Full Text] [Related]
20. The Promise of Proteomics for the Study of ADP-Ribosylation.
Daniels CM; Ong SE; Leung AK
Mol Cell; 2015 Jun; 58(6):911-24. PubMed ID: 26091340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]